Glaxosmithkline Pharmaceuticals
⚠️ Moderate Risk
FEI: 3012212307 • Lagos, Cross River State • NIGERIA
FEI Number
3012212307
Location
Lagos, Cross River State
Country
NIGERIAAddress
Agbaso Rd Agbara, , Lagos, Cross River State, Nigeria
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
Frequently Asked Questions
What is Glaxosmithkline Pharmaceuticals's FDA import refusal history?
Glaxosmithkline Pharmaceuticals (FEI: 3012212307) has 3 FDA import refusal record(s) in our database, spanning from 4/20/2016 to 11/29/2022.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxosmithkline Pharmaceuticals's FEI number is 3012212307.
What types of violations has Glaxosmithkline Pharmaceuticals received?
Glaxosmithkline Pharmaceuticals has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Glaxosmithkline Pharmaceuticals come from?
All FDA import refusal data for Glaxosmithkline Pharmaceuticals is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.